HomeCLN • WSE
add
Celon Pharma SA
Previous close
zł 24.80
Day range
zł 24.20 - zł 24.75
Year range
zł 14.62 - zł 32.90
Market cap
1.33B PLN
Avg Volume
24.43K
P/E ratio
67.99
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 51.05M | 5.64% |
Operating expense | -23.03M | -154.84% |
Net income | 57.18M | 938.96% |
Net profit margin | 112.00 | 894.33% |
Earnings per share | — | — |
EBITDA | 65.97M | 2,293.61% |
Effective tax rate | 1.23% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 103.28M | 1.31% |
Total assets | 619.15M | 7.70% |
Total liabilities | 102.91M | -10.42% |
Total equity | 516.25M | — |
Shares outstanding | 53.86M | — |
Price to book | 2.59 | — |
Return on assets | 23.54% | — |
Return on capital | 28.00% | — |
Cash Flow
Net change in cash
| (PLN) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 57.18M | 938.96% |
Cash from operations | -14.73M | -281.72% |
Cash from investing | -4.06M | 29.18% |
Cash from financing | -1.42M | 74.38% |
Net change in cash | -20.20M | -543.06% |
Free cash flow | 32.56M | 1,251.22% |
About
Founded
2002
Website
Employees
562
